MRC1 and neoplasm: Results showed that anti-IFN-γ treatment greatly down-regulated the CD86 expression level of tumor-infiltrating macrophages while up-regulated the CD206 expression of tumor-infiltrating macrophages (Additional file 1: Figure S2).